Online Database of Chemicals from Around the World
| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 862588-62-3 | 3-(4-Chlorophenyl)-1-methyl-1H-pyrazol-5-ol | C10H9ClN2O |
| 862599-47-1 | Ethyl 2-chloro-oxazole-5-carboxylate;2-Chlorooxazole-5-carboxylic acid ethyl ester; Ethyl 2-chloro-1,3-oxazole-5-carboxylate | C6H6ClNO3 |
| 862686-09-7 | 1-[4-(4-Amino-2-Methylphenyl)-1-Piperazinyl]-Ethanone | |
| 862723-42-0 | 1H-Indazole-5-boronic acid pinacol ester;5-(4,4,5,5-Tetramethyl-(1,3,2)dioxaborolan-2-yl)-1H-indazole; Indazole-5-boronic acid pinacol ester | C13H17BN2O2 |
| 862731-66-6 | 1-Octyl-3-methylimidazolium bis(2,2,2-trifluoroacetyl)imide;1-Methyl-3-octyl-1H-imidazolium salt with 2,2,2-trifluoro-N-(trifluoroacetyl)acetamide | C12H23N2.C4F6NO2 |
| 862772-11-0 | Cyclo(L-arginylglycyl-L-alpha-aspartyl-D-phenylalanyl-L-cysteinyl) | C24H34N8O7S |
| 862776-43-0 | 1-(2-Chloro-4-nitrophenyl)-1H-imidazole | C9H6ClN3O2 |
| 862812-98-4 | 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(methylsulfonyl)benzyl]oxy}-2-thiophenecarbonitrile | C22H19N3O5S2 |
| 862847-75-4 | 7-Bromo-9,9,9',9'-tetraethyl-2,2'-bifluorene | C34H33Br |
| 862874-75-7 | 2-Methyl-2-propanyl 3-(4-aminophenoxy)-1-pyrrolidinecarboxylate | C15H22N2O3 |
| 862894-96-0 | Bortezomib Impurity 4;(S)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide | C19H22N4O3 |
| 862895-00-9 | Bortezomib Impurity 11;N-((1S)-2-(((1E)-3-Methyl-1-buten-1-yl)amino)-2-oxo-1-(phenylmethyl)ethyl)-2-pyrazinecarboxamide | C19H22N4O2 |
| 862901-87-9 | (alphaS)-alpha-((1,1'-Biphenyl)-4-yloxy)benzenepropanoic acid;LT 175 | C21H18O3 |
| 862996-27-8 | (2R,4S)-4-Hydroxy-1,2-pyrrolidinedicarboxylic acid bis(1,1-dimethylethyl) ester | C14H25NO5 |
| 863015-82-1 | 1,3,4-Oxathiazinane 3,3-dioxide | C3H7NO3S |
| 863028-98-2 | 4-(Methylamino)-2-(methylsulfanyl)-5-pyrimidinecarboxylic acid | C7H9N3O2S |
| 863029-89-4 | 2-(((4-Chloro-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-6-methoxy-1H-benzimidazole | C16H16ClN3O2S |
| 863031-21-4 | Azilsartan medoxomil;TAK 491; 1-((2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)(1,1'-biphenyl)-4-yl)methyl)-2-ethoxy-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester | C30H24N4O8 |
| 863031-24-7 | Azilsartan kamedoxomil;1-((2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)(1,1'-biphenyl)-4-yl)methyl)-2-ethoxy-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester potassium salt | C30H23N4O8.K |
| 863032-29-5 | Methyl 4-pyrimidinylacetate | C7H8N2O2 |
| 863090-89-5 | 2,2,3,3,4,4-Hexafluoro-4-(trifluoromethoxy)butanoic acid | C5HF9O3 |
| 863111-48-2 | 2-Bromo-5-chloro-4-(trifluoromethyl)benzenamine | C7H4BrClF3N |
| 863118-41-6 | Methyl 6-(trifluoromethyl)-1-benzothiophene-2-carboxylate | C11H7F3O2S |
| 863127-76-8 | (E)-N-(2-Chloro-6-methylphenyl)-3-ethoxyacrylamide;(2E)-N-(2-Chloro-6-methylphenyl)-3-ethoxy-2-propenamide | C12H14ClNO2 |
| 863127-77-9 | Dasatinib monohydrate;N-(2-Chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-5-thiazolecarboxamide monohydrate | C22H26ClN7O2S.H2O |
| 863216-51-7 | 5-Amino-1H-benzimidazole-6-carboxylic acid | C8H7N3O2 |
| 863238-73-7 | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-pyrazole | C28H29BN2O2 |
| 863239-60-5 | Glyco Obeticholic Acid;3a,7a-dihydroxy-6a ethyl-5b-cholan-24-ol ; (3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta(a)phenanthrene-3,7-diol | C28H47NO5 |
| 863239-61-6 | Obeticholic acid metabolite UPF-1443;Tauro-Obeticholic Acid;2-(((4R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta(a)phenanthren-17-yl)pentanoyl)amino)ethanesulfonic acid | C28H49NO6S |
| 863248-20-8 | 3-Morpholinophenylboronic acid hydrochloride;(3-(4-Morpholinyl)phenyl)boronic acid hydrochloride | C10H14BNO3.HCl |
| 863248-21-9 | B-[4-(Ethylsulfinyl)Phenyl]-Boronic Acid | C8H11BO3S |
| 863248-36-6 | (2-Fluoro-5-propoxyphenyl)boronic acid | C9H12BFO3 |
| 863248-45-7 | N-Methyl-N-(3-piperidinyl)acetamide | C8H16N2O |
| 863304-76-1 | 4-(tert-Butoxycarbonylamino)bicyclo(2.2.2)octane-1-carboxylic acid | C14H23NO4 |
| 863305-81-1 | 4-(3-Chloro-2-thienyl)-6-methyl-2-pyrimidinamine | C9H8ClN3S |
| 863307-54-4 | (1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-3-oxo-2-piperazinyl)acetic acid | C11H18N2O5 |
| 863323-03-9 | 1-Iodo-4-(1,1,2,2-tetrafluoroethoxy)benzene | C8H5F4IO |
| 863329-65-1 | (2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine 3',5'-dibenzoate | C24H21FN2O7 |
| 863329-66-2 | (2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine;RO 2433; PSI-6206; 1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | C10H13FN2O5 |
| 863377-22-4 | 3-Morpholinophenylboronic acid;(3-(4-Morpholinyl)phenyl)boronic acid | C10H14BNO3 |
| 863391-64-4 | 3-(4-BroMophenyl)isoxazole-5-carboxaldehyde | |
| 863394-07-4 | Se-(Methyl)-selenocysteine hydrochloride | C4H9NO2Se.HCl |
| 863411-69-2 | 2-(2-Bromophenoxy)-N-methylacetamide | C9H10BrNO2 |
| 863422-41-7 | 2-(Pyridazin-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C10H15BN2O2 |
| 863492-35-7 | 2-Aminoquinoline-6-carboxylic acid benzyl ester | C17H14N2O2 |
| 863504-84-1 | tert-Butyl 3-aminopyrazole-1-carboxylate;3-Aminopyrazole-1-carboxylic acid tert-butyl ester; tert-Butyl 3-amino-1H-pyrazole-1-carboxylate | C8H13N3O2 |
| 863513-91-1 | Cebranopadol;(1alpha,4beta)-6'-Fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine; GRT 6005 | C24H27FN2O |
| 863548-52-1 | 1-Methyl-1H-pyrazole-5-methanamine;1-(1-Methyl-1H-pyrazol-5-yl)methanamine | C5H9N3 |
| 863578-21-6 | 2-Amino-4-chlorophenyl boronic acid pinacol ester | C12H17BClNO2 |
| 863578-24-9 | 2-Amino-5-Fluorophenyl Boronic Acid Pinacol Ester |